Noticias y Actividades de Enveric Biosciences
Presencia
Sede: Estados Unidos
Enveric Biosciences es una empresa que cotiza bajo el símbolo de cotización ENVB (US).
Ejecutivos
Ver el organigrama con sus 11 ejecutivos principales
Biografías más buscadas en Enveric Biosciences
- Joseph Tucker, Chief Executive Officer and Director
- Michael Webb, Chairman of the Board
- Frank Pasqualone, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Enveric Biosciences.
Biotecnología
Enveric Biosciences tiene 2.430 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).
Popular M&A news in Biotecnología
- Tempus has announced the acquisition of Personalis (publicado el 20 de julio de 2026).
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado el 17 de julio de 2026).
- GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Enveric Biosciences
- Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025” – Enveric Biosciences
- Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025” – Enveric Biosciences
- Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds – Enveric Biosciences
- Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior – Enveric Biosciences
- Press Releases – Enveric Biosciences
- Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results – Enveric Biosciences
- Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002 – Enveric Biosciences
- Enveric Biosciences Announces Broad Range of Patent Issuances – Enveric Biosciences
- Enveric Biosciences Announces Broad Range of Patent Issuances – Enveric Biosciences
- Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003 – Enveric Biosciences
- View more press releases Close
Redes sociales sobre Enveric Biosciences
- Enveric Biosciences en Wikipedia, Google News y Yahoo Finance
- Enveric Biosciences en LinkedIn, Twitter y YouTube
